BioQuest Corp. (BQST)
USD 1.05
(0.96%)
USD 1.05
(0.96%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -62.68 Thousand | -53.5 Thousand | -116.72 Thousand | -193.2 Thousand | -124.83 Thousand | 2.18 |
| Net Income | -123.32 Thousand | -140.66 Thousand | -821.02 Thousand | -2.32 Million | -359.02 Thousand | -2175.00 |
| Depreciation & Amortization | - | - | 24.09 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 50 Thousand | - | 206.7 Thousand | 530 Thousand | 117.27 Thousand | - |
| Change in working capital | 18.28 Thousand | 37.15 Thousand | 549.02 Thousand | 1.47 Million | 116.92 Thousand | 2175.00 |
| Other non-cash items | -7642.00 | 50 Thousand | -75.51 Thousand | 125.62 Thousand | 117.27 Thousand | 2175.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 35 Thousand | 20 Thousand | 150 Thousand | 193.3 Thousand | 125 Thousand | - |
| Debt repayment | - | -20 Thousand | -85 Thousand | -58.3 Thousand | -40 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 65 Thousand | 135 Thousand | 55 Thousand | - |
| Other Financing Activities | 35 Thousand | 20 Thousand | 170 Thousand | 116.6 Thousand | 110 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | 6676.00 | 156.58 Thousand | 36.51 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 18.28 Thousand | 37.15 Thousand | 542.34 Thousand | 1.31 Million | 80.41 Thousand | 2175.00 |
| Cash at beginning of period | 31.00 | 33.54 Thousand | 260.00 | 166.00 | - | - |
| Cash at end of period | -27.65 Thousand | 31.00 | 33.54 Thousand | 260.00 | 166.00 | 2.18 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -27.68 Thousand | -33.5 Thousand | 33.28 Thousand | 94.00 | 166.00 | 2.18 |
| Free Cash Flow | -62.68 Thousand | -53.5 Thousand | -116.72 Thousand | -193.2 Thousand | -124.83 Thousand | 2.18 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -123.32 Thousand | -84.81 Thousand | -14.2 Thousand | -9860.00 | -14.4 Thousand | -140.66 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 50 Thousand | 50 Thousand | - | - | - | - |
| Change in working capital | 10.63 Thousand | -14.77 Thousand | 14.59 Thousand | 9671.00 | 14.41 Thousand | 37.15 Thousand |
| Other non-cash items | 50 Thousand | -13.13 Thousand | -368.81 | 179.05 | - | 50 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 35 Thousand | 35 Thousand | - | - | - | 20 Thousand |
| Debt repayment | - | - | - | - | - | -20 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 35 Thousand | 35 Thousand | - | - | - | 20 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.63 Thousand | -14.77 Thousand | 14.59 Thousand | 9671.00 | 14.41 Thousand | 37.15 Thousand |
| Cash at beginning of period | 31.00 | 54.00 | 26.00 | 36.00 | 31.00 | 33.54 Thousand |
| Cash at end of period | 5914.00 | -27.65 Thousand | 54.00 | 26.00 | 36.00 | 31.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5883.00 | -27.71 Thousand | 28.00 | -10.00 | 5.00 | -33.5 Thousand |
| Free Cash Flow | -62.68 Thousand | -62.71 Thousand | 28.04 | -9.95 | 5.00 | -53.5 Thousand |
688606
BAF
688050
000547
EXXRF
MVI